GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (BOM:544210) » Definitions » Common Stock

Emcure Pharmaceuticals (BOM:544210) Common Stock : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals Common Stock?

Emcure Pharmaceuticals's quarterly common stock increased from Mar. 2024 (₹1,812 Mil) to Sep. 2024 (₹1,891 Mil) but then declined from Sep. 2024 (₹1,891 Mil) to Dec. 2024 (₹0 Mil).

Emcure Pharmaceuticals's annual common stock stayed the same from Mar. 2022 (₹1,809 Mil) to Mar. 2023 (₹1,809 Mil) but then increased from Mar. 2023 (₹1,809 Mil) to Mar. 2024 (₹1,812 Mil).


Emcure Pharmaceuticals Common Stock Historical Data

The historical data trend for Emcure Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals Common Stock Chart

Emcure Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Common Stock
1,808.52 1,808.52 1,808.52 1,811.52

Emcure Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial 1,808.52 - 1,811.52 1,890.98 -

Emcure Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Emcure Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines